ZAGREB, March 8 (Hina) - The Croatian pharmaceutical company Pliva had a successful financial year in 2001, earning 1.095 billion kuna (EUR148.6 million) in net profits, which is 3.6 percent less than in 2000, but an increase of 9.3
percent when the return of pre-paid taxes and the fact that the profit tax rate is 20 percent are taken into account. Earning per share is 57.44 kuna. Pliva's management and supervisory board will propose to shareholders paying out a dividend in the gross amount of 15 kuna per share. This is 25 percent more than the dividend paid in 2000. The total income earnings of the Pliva group in 2001, the company's 80th year, exceeded 5.27 billion kuna, which is a 6.2 percent increase in relation to 2000. Sumamed is still the best selling prescription drug, with 342.2 million kuna earned. Earnings on foreign markets in 2001 amounted to 3.97 billion kuna, which is an inc
ZAGREB, March 8 (Hina) - The Croatian pharmaceutical company Pliva
had a successful financial year in 2001, earning 1.095 billion kuna
(EUR148.6 million) in net profits, which is 3.6 percent less than in
2000, but an increase of 9.3 percent when the return of pre-paid
taxes and the fact that the profit tax rate is 20 percent are taken
into account.
Earning per share is 57.44 kuna. Pliva's management and supervisory
board will propose to shareholders paying out a dividend in the
gross amount of 15 kuna per share. This is 25 percent more than the
dividend paid in 2000.
The total income earnings of the Pliva group in 2001, the company's
80th year, exceeded 5.27 billion kuna, which is a 6.2 percent
increase in relation to 2000. Sumamed is still the best selling
prescription drug, with 342.2 million kuna earned.
Earnings on foreign markets in 2001 amounted to 3.97 billion kuna,
which is an increase of 16.6 percent. Pliva's earnings on
international markets rose from 71.8 to 75.4 percent.
Last year saw an intensive research of new chemical entities and
development of generics. Pliva submitted 14 requests for the
registration of new generics in countries of Central and Eastern
Europe, of which eight received registrations, and 11 in Western
European countries.
The overall value of the company rose from 7.55 billion to 8.08
billion kuna, and the investments during 2001 reached 952 million
kuna, of which 518 million were capital investments.
The Pliva management estimates in 2002 the rate of operational
profit will remain at 20 percent, the investments will amount to 600
million kuna, and the earning per share will increase by at least 20
percent.
According to December 31, 2001 data, institutional investors (GDR
owners) hold 61.01 percent of shares, the Croatian Institute for
Pension Insurance 18.03 percent, EBRD 5.43 percent, ESOP programme
(workers) 1.51 percent, the Capital fund 1.27 percent, HFP 0.70
percent, there are 5.87 treasury shares, and 6.18 percent of shares
owned by other private stockholders.
(EUR1 = 7.4 kuna)
(hina) np sb